These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32646991)

  • 41. Possible method for the production of a Covid-19 vaccine.
    Myint A; Jones T
    Vet Rec; 2020 Mar; 186(12):388. PubMed ID: 32221001
    [No Abstract]   [Full Text] [Related]  

  • 42. COVID-19 vaccines: no time for complacency.
    The Lancet
    Lancet; 2020 Nov; 396(10263):1607. PubMed ID: 33220729
    [No Abstract]   [Full Text] [Related]  

  • 43. Development of vaccines for SARS-CoV-2.
    Ng WH; Liu X; Mahalingam S
    F1000Res; 2020; 9():. PubMed ID: 32850116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Understanding COVID-19 vaccine efficacy.
    Lipsitch M; Dean NE
    Science; 2020 Nov; 370(6518):763-765. PubMed ID: 33087460
    [No Abstract]   [Full Text] [Related]  

  • 45. The Ethics of COVID-19 Immunity-Based Licenses ("Immunity Passports").
    Persad G; Emanuel EJ
    JAMA; 2020 Jun; 323(22):2241-2242. PubMed ID: 32374357
    [No Abstract]   [Full Text] [Related]  

  • 46. The Covid-19 Vaccine-Development Multiverse.
    Heaton PM
    N Engl J Med; 2020 Nov; 383(20):1986-1988. PubMed ID: 32663910
    [No Abstract]   [Full Text] [Related]  

  • 47. A SARS-CoV-2 mRNA Vaccine - Preliminary Report.
    Schaefer JR; Sharkova Y; Nickolaus T
    N Engl J Med; 2020 Sep; 383(12):1191. PubMed ID: 32813941
    [No Abstract]   [Full Text] [Related]  

  • 48. Developing a SARS-CoV-2 Vaccine at Warp Speed.
    O'Callaghan KP; Blatz AM; Offit PA
    JAMA; 2020 Aug; 324(5):437-438. PubMed ID: 32628244
    [No Abstract]   [Full Text] [Related]  

  • 49. Audio Interview: Guidelines for Covid-19 Vaccine Deployment.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Sep; 383(11):e88. PubMed ID: 32905696
    [No Abstract]   [Full Text] [Related]  

  • 50. Melanie Saville: the end-to-end process needed for a SARS-CoV-2 vaccine.
    Bull World Health Organ; 2020 Sep; 98(9):588-589. PubMed ID: 33012858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Race to Develop a COVID-19 Vaccine.
    Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A SARS-CoV-2 mRNA Vaccine - Preliminary Report. Reply.
    Jackson LA; Roberts PC; Graham BS
    N Engl J Med; 2020 Sep; 383(12):1191-1192. PubMed ID: 32813942
    [No Abstract]   [Full Text] [Related]  

  • 53. What Would Jenner and Pasteur Have Done About COVID-19 Coronavirus? The Urges of a Vaccinologist.
    Palatnik-de-Sousa CB
    Front Immunol; 2020; 11():2173. PubMed ID: 32983183
    [No Abstract]   [Full Text] [Related]  

  • 54. Progress and Concept for COVID-19 Vaccine Development.
    Wu SC
    Biotechnol J; 2020 Jun; 15(6):e2000147. PubMed ID: 32304139
    [No Abstract]   [Full Text] [Related]  

  • 55. Intensifying vaccine production.
    Bull World Health Organ; 2020 May; 98(5):302-303. PubMed ID: 32514194
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tracking a Vaccine and Developing Therapeutics for COVID-19.
    Gould KA
    Dimens Crit Care Nurs; 2020; 39(6):293-297. PubMed ID: 33009266
    [No Abstract]   [Full Text] [Related]  

  • 57. COVID-19 vaccines: early success and remaining challenges.
    Bar-Zeev N; Inglesby T
    Lancet; 2020 Sep; 396(10255):868-869. PubMed ID: 32896290
    [No Abstract]   [Full Text] [Related]  

  • 58. Severe Acute Respiratory Syndrome Coronavirus 2 Human Challenge Trials: Too Risky, Too Soon.
    Dawson L; Earl J; Livezey J
    J Infect Dis; 2020 Jul; 222(3):514-516. PubMed ID: 32496536
    [No Abstract]   [Full Text] [Related]  

  • 59. Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.
    Logunov DY; Dolzhikova IV; Tukhvatullin AI; Shcheblyakov DV
    Lancet; 2020 Oct; 396(10256):e54-e55. PubMed ID: 32971043
    [No Abstract]   [Full Text] [Related]  

  • 60. Planning for a COVID-19 Vaccination Program.
    Schaffer DeRoo S; Pudalov NJ; Fu LY
    JAMA; 2020 Jun; 323(24):2458-2459. PubMed ID: 32421155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.